Previously, we reported that osmotin and osmotin derived nanopeptide, adipoR1 agonists, regulated brain energy metabolism, and mitigated neuropathological deficits through AdipoR1/AMPK signaling in AD and Adiponectin−/− mice [33,65]). This evidence concerns the gene ADIPOR1 and Alzheimer disease.